Dr. Tong Guo

Dr. Tong Guo is CEO of Gem Flower Pharma Tech., an Academic Research Organization (ARO) based in Beijing China. Prior to his current role, Dr. Guo was Vice President and Head of Business Development at IQVIA China; and the Head of Biostatistics Africa & Asia and managed the off-shore Biostatistics functions at IQVIA/Quintiles since 2015. Before joining IQVIA, Dr. Guo used to work as the Head of Global Data Sciences & Analytics Beijing R&D Center at Bayer HealthCare; Vice-President and Head of Clinical Informatics & FSP at WuXiPRA, a joint venture co-founded by PRA International and WuXi AppTec.

​

Dr. Guo began his clinical research career in 1998 as a Biostatistician at McMaster University in Ontario, Canada. He was a Biostatistician in the United States in both CRO (MDS Pharma Services) and pharmaceutical companies (Bristol-Myers Squibb and Johnson & Johnson) with increasing responsibilities. Tong received his M.Sc and Ph.D. degrees in Biostatistics from McGill University, Montreal Canada.

​

Dr. Guo is currently a member of the DIA China Advisory Committee. Dr. Guo has 20+ years of research experience in the design and analysis of clinical trial design and analysis, causal inference methodology, and real-world data trial design and analysis